182 related articles for article (PubMed ID: 7645970)
1. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. II. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl nitrosoureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):853-8. PubMed ID: 7645970
[TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. I. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl ureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):847-52. PubMed ID: 7645969
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity and differential cellular sensitivity of new N-methyl and N-propargyl urea and nitrosourea derivatives of diamino acids against sixty human NCI tumor cell lines.
Gallant G; Salvador R; Dulude H
Anticancer Res; 1993; 13(1):133-9. PubMed ID: 8476204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary in vitro cytotoxicity evaluation of 1,3-bis-(2-propynyl)-1-nitrosourea (BPNU) and derivatives.
Gallant G; Salvador R; Dulude H
Anticancer Res; 1994; 14(6B):2695-9. PubMed ID: 7872704
[TBL] [Abstract][Full Text] [Related]
5. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activity of nitrosourea antitumor agents.
Franza BR; Oeschger NS; Oeschger MP; Schein PS
J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
[TBL] [Abstract][Full Text] [Related]
7. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
Gugova RG; Raikov ZD; Zakhariev SG; Demirov GD; Todorov DK; Ilarionova MV
Drugs Exp Clin Res; 1989; 15(10):497-500. PubMed ID: 2632217
[TBL] [Abstract][Full Text] [Related]
10. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
Weinkam RJ; Dolan ME
J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Oguro M; Yanagawa T; Takenaga K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary in vitro evaluation of antitumor nitrosoureido cholesterol derivatives.
Elkihel L; Gelin M; Letourneux Y
Arzneimittelforschung; 1995 Feb; 45(2):190-4. PubMed ID: 7710447
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
16. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
Alvarez M; Paull K; Monks A; Hose C; Lee JS; Weinstein J; Grever M; Bates S; Fojo T
J Clin Invest; 1995 May; 95(5):2205-14. PubMed ID: 7738186
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro.
Hu K; Yao XS
Anticancer Res; 2002; 22(2A):1001-5. PubMed ID: 12014616
[TBL] [Abstract][Full Text] [Related]
18. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
20. [Viability and proliferative activity of a Chinese hamster cell culture exposed to nitrosoureas in exponential and stationary growth phases].
Makarova GF; Epifanova OI; Loginov BV; Gorbacheva LB
Tsitologiia; 1987 Feb; 29(2):221-6. PubMed ID: 3576702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
